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Abstract Epidermal growth factor (EGF) modulates several functions of human enterocytes. We report that this growth factor induces strong 
tyrosine phosphorylation stimulation of its receptor and several putative substrates of the receptor intrinsic kinase including c-erb B2 in proliferating 
human colon carcinoma cells (C&o-2). In addition EGF induces table association of the GTP-ase activating protein of ~21” to the p190 protein 
and to a 62 mol.wt. tyrosine-phosphorylated protein. This association is probably consequent toEGF stimulation of protein tyrosine phosphorylation 
and could coordinate progression through cell cycle with polarity, cell-cell interactions and cell mobility. 
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1. Introduction 
EGF stimulates proliferation of intestinal cells [l] modulates 
in vitro human enterocyte (Caco-2) migration [2], and main- 
tains the integrity of the gastrointestinal mucosa [3]. In addi- 
tion, gene expression of a trefoil peptide PS2, member of a 
growing family of proteins associated with mucosal repair and 
suspected to be involved in neoplasms of the gastrointestinal 
tract, is regulated by EGF [4]. The Caco-2 cells, derived from 
human colon carcinoma [5,6] contain about 6,000 EGF-R per 
cell unevenly distributed between the apical and basolateral 
membrane [7,8] and respond to EGF with growth [9]. 
We observe that in subconfluent, proliferating Caco-2 cells 
EGF strongly increases the basal level of tyrosine phosphoryl- 
ation of its own receptor and several other proteins which are 
putative substrates of EGF-R including c-erb B2 (also called 
neu or HER-2). In addition EGF induces stable association of 
~190, a recently cloned protein [lo], to ras-GAP (the ~120 
GTP-ase activating protein), likely through ~190 tyrosine phos- 
phorylation. ~190 association with ras-GAP is increased uring 
tyrosine kinase mediated cell proliferation and this association 
reduces the GTP-ase stimulatory activity of ras-GAP [l l] in- 
creasing the active form of ras [12]. It has recently been ob- 
served that ~190 is endowed with a GAP activity specific for 
rho, a ras-related protein family [13]. Therefore complex for- 
mation between ras-GAP and ~190 following growth-factor 
stimulation offers a mechanism to couple signals mediated by 
~21’” and rho GTP-ases [ 131. Since rho proteins regulate actin 
cytoskeleton [ 14,151 and cell polarity [16] whereas ~21” 
transduces signals for mitogenesis, our data suggest hat the 
EGF-dependent ras-GAP-p190 association coordinates pro- 
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saline; PMSF, phenyl-methyl-sulfonyl-fluoride; ras-GAP, ras-GTP-ase 
activating protein; TEMED, N,N,W,N’-tetramethyl-ethylene-diamine; 
Tris, Tris Ihydroximethyl]-aminomethane. 
gression through the cell cycle with polarity, cell-cell interac- 
tions and motility of intestinal cells. In addition, EGF stimu- 
lates tyrosine phosphorylation and/or ras-GAP association of 
a 62 kDa protein, very likely to be the p62 protein [17]. 
2. Materials and methods 
2.1. Materials 
Human recombinant EGF was from Boehringer (Mannheim, Ger- 
many). Mouse monoclonal anti EGF-R antibodies, mouse monoclonal 
Ig2bk anti-P-tyrosine antibodies (clone 4GlO), polyclonal rabbit anti- 
GAP antibodies were from Upstate Biotechnology Inc. (Lake Placid, 
NY, USA). Polyclonal rabbit anti-c-erbB-2 antibodies (M6) were a 
generous gift from Dr. P.P. Di Fiore (Molecular Biology Laboratory 
of NCI, NIH, Bethesda, MD, USA). Anti p-190 rabbit antisera were 
a gift from Dr. J. Settleman (MGH Cancer Center, Charlestown, MA, 
USA). Anti-mouse and anti-rat IgG, alkaline phosphatase conjugates 
were from Promega (Madison, WI, USA). Reagents for cell culture 
media including foetal calf serum were from Gibco (Gaithersburg, MD, 
USA). 
2.2. Cell culture and EGF treatment 
Caco-2 cells were a generous gift from Dr. G. Tritto (Cattedra di 
Gastroenterologia, Universita di Napoli “Federico II”, Napoli, Italy). 
They were routinely grown in 10% CO2 in air atmosphere using Dul- 
becco modified Eagle’s medium (DMEM) supplemented with Phenol 
red, L-glutamine (2 mM), penicillin (100 U .ml-I), streptomycin 
(lOO~g~tn-‘), 10 mM HEPES and 10% foetal calf serum. Subconfluent 
cells grown in 100 or 145 mm Petri dishes were kept in the same medium 
lacking foetal calf serum and added to 25 pg.rnl-’ transferrin, 25 
ng .ml-’ insulin and 20 mM sodium selenite for 18 h before 
the EGF treatment. Cells were then incubated with or without EGF at 
indicated concentrations for 15 min. 
2.3. Analysis of tyrosine phosphorylation and immunopuriJication by 
anti-P-tyrosine antibodies of total proteins from EGF-treated 
CaCo-2 cells 
Cells were washed with ice-cold phosphate-buffered saline (PBS), pH 
7.4, scraped and added to 1 ml of lysis buffer: 50 mM Tris-HCl, EDTA 
4 mM, 150 mM KCl, 1 mM PMSF, 1 pg.rnl-’ of each antipain, 
leupeptin and pepstatin, 10 pg.rnl-’ of soy bean trypsin inhibitor, 
1 mM sodium orthovanadate and 1% Triton X-100, pH 7.4. The lysate 
was diluted with lysis buffer to a final concentration of 2.5 mg *ml-’ of 
proteins. Hundred pg of proteins were mixed with Laemmli sample 
buffer and submitted to SDS-PAGE followed by blot with anti-P- 
tyrosine antibodies, In the immunopurification experiments by anti-P- 
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tyrosine antibodies 1 ml of cell lysate was diluted with 1 ml of lysis 
buffer lacking Triton X-100 and incubated overnight with 100 ~1 of 
anti-P-tyrosine antibodies linked to agarose. The suspension was centri- 
fuged and the beads were washed with lysis buffer containing 0.1% 
Triton X-100 (washing buffer) and proteins eluted by incubating the 
beads with 100 ~1 of Laemmli sample buffer for 3 min at 100°C. The 
eluate was submitted to SDS-PAGE and blotted with either anti-P- 
tyrosine or anti-EGF-R antibodies. 
2.4. Imrnunopurification of EGF-R 
One ml lysate was diluted with lysis buffer to a final concentration 
of 2.5 mgml-’ of proteins and incubated for 1 h witb 5 pg of mouse 
IgG and 40 ~1 of protein G-sepharose (50% suspension). The samples 
were centrifuged and supematants incubated overnight with 5 pg.ml-’ 
of either control or anti EGF-R antibodies. Each sample was added to 
120 ~1 of protein G-Sepharose (50% suspension) and incubated for an 
additional hour. The samples were centrifuged, the pellets were washed 
with washing buffer and proteins eluted by boiling in 150 ~1 of Laemmli 
sample buffer. The eluates were submitted to electrophoresis and blot- 
ted with either anti-P-tyrosine or anti-EGF-R antibodies. 
2.5. Immunopurification of c-erb 82 
Cells were added to 1.2 ml of lysis buffer containing 1% aprotinin in 
addition to the other components. The lysate was diluted with lysis 
buffer to a tinal concentration of 4.5 mg.rn-’ of proteins. Two 500@ 
fractions were incubated for 1 h with 5 pg of either rabbit control or 
M6 anti-c-erb B2 polyclonal antibodies. Then 70 ~1 of protein G- 
Sepharose suspension (50% in lysis buffer, v/v) was added to each 
sample and the incubation continued for 45 min. The pellets were 
collected by centrifugation, washed with 1 ml of lysis buffer, then eluted 
by boiling in 70 ~1 of Laemmli sample buffer. The eluates were resolved 
on SDS-PAGE and blotted with either anti-c-erb B2 or anti-P-tyrosine 
antibodies. 
2.6. Irrununopurt$cation of w-GAP and ras-GAP-associated proteins 
The lysate was diluted with lysis buffer to a tinal protein concentra- 
tion of about 1.5 mg .ml-’ and incubated for 1 h with 1 ,ug .ml-’ of 
rabbit IgG and 100 ~1 of protein G-Sepharose suspension. The sample 
was centrifuged and the supematant incubated with either 8 pg*ml-’ 
of rabbit IgG or 8 pg .rnl-’ rabbit polyclonal anti-ras-GAP antibodies 
overnight at 4°C. The samples were then added to 70~1 of protein 
G-sepharose and incubated for additional 90 min. They were centri- 
fuged and pellets washed with washing buffer and eluted by boiling in 
120 ~1 of Laemmli sample buffer. Each eluate was submitted to electro- 
phoresis and blotted with either anti-P-tyrosine or anti-ras-GAP or 
anti-p190 antibodies. 
To immunoprecipitate the ras-GAP associated ~190, 1 ml of lysate 
prepared and diluted as described above was incubated for 1 h with 
1 pg.rnl-’ of rabbit IgG and 80 ~1 of protein G-Sepharose 
suspension. The sample was centrifuged and the supematant incubated 
overnight with either 2,~g.rnl-’ of rabbit IgG or 2pg.ml-’ of rabbit 
polyclonal anti-p190 antibodies. The samples were then added to 60 ~1 
of protein G-sepharose and incubated for further 60 min. They were 
centrifuged, washed and eluted by boiling in 120 ~1 of Laemmli sample 
buffer. The eluates were submitted to SDS-PAGE and blotted with 
either anti-P-tyrosine or anti-p190 antibodies. 
2.7. Electrophoresis and imrnunoblotting 
Sixty ,ul samples were submitted to SDS-PAGE (7.5% acrylamide, 
acrylamide/BIS ratio 37,5: 1) using 10 x 15 cm gels. After separation, 
proteins were electrophoretically blotted onto nitrocellulose filters 
(S&S BA 85) at 25 V overnight at room temperature by using a transfer 
buffer containing 50 mM Tris, 380 mM glycine, 0.1% SDS and 20% 
methanol. The nitrocellulose filters were soaked in 10 mM Tris-HCl, 
150 mM NaCl, 0.05% Tween-20, pH 8.0 (TBST buffer) containing 3% 
BSA (blocking solution) and incubated for about 2 h. They were then 
incubated for a further 2-3 h, with either anti-P-tyrosine or anti-EGF- 
R antibodies (1 pg. ml-’ in blocking solution) or anti-ras-GAP (1: 1000 
dilution) or anti-p190 antibodies (1: 500 dilution) of M6 anti-c-erb B2 
antibodies (1: 1000 dilution); thereafter pellets were collected and 
washed for 10 min with TBST buffer. The filters treated with anti-P- 
tyrosine or anti-EGF-R antibodies were incubated with alkaline phos- 
phatase-linked anti-mouse IgG antibodies (1:4000 dilution in TBST 
buffer) and the filters treated with anti-ras-GAP or anti-p190 or anti- 
c-erb B2 antibodies were incubated with alkaline phosphatase-linked 
anti-rabbit IgG antibodies (1: 7500 dilution in TBST buffer) for 45 min 
at room temperature. Finally, filters were washed again and protein- 
antibody complexes revealed according to the instructions of manufac- 
turer. 
3. Results 
3.1. Dependence of total protein tyrosine phosphorylation on 
EGF concentration 
Caco-2 cells untreated or treated for 15 min with different 
concentrations (from 1 to 100 ngaml-’ of medium) of EGF 
were lysed; the lysates were submitted to SDS-PAGE and blot- 
ted with anti-P-tyrosine antibody. In the absence of exogenous 
EGF (0 lane) several tyrosine phosphorylated proteins were 
detected (Fig. 1). EGF treatment stimulated tyrosine phospho- 
rylation of some of these proteins. The strongest stimulation 
was observed at 100 ng.ml-’ (16 nM) EGF. In other experi- 
ments optimal stimulation was detected at 200 ng .ml-’ EGF. 
The most strongly stimulated protein is one which like the 
EGF-R migrated at 170.000 mol.wt. Minor although significant 
stimulation of phosphorylation of a 185.000 mol.wt. protein 
was detected (Fig. 1) at the highest EGF concentration. Its 
molecular weight corresponded to c-erb B2 which is also a 
receptor-associated tyrosine kinase. 
3.2. Purijkation ofproteins by anti-P-tyrosine antibody coupled 
to agarose followed by blots with either anti-P-tyrosine or 
anti-EGF-R antibodies 
Lysates from subcontluent Caco-2 cells untreated or treated 
with EGF were incubated with beads of anti-l-tyrosine-aga- 
EGF(ng) 0 1 10 loo 
70 
Fig. 1. Tyrosine phosphorylation of subconfluent Caco-2 cell proteins: 
EGF dose-response. Serum-starved cells were not treated (lane 0) or 
treated with different concentrations (1, 10 and 100 ng .ml-‘) of EGF 
for 15 min at 37°C then lysed. Total cellular proteins (1OOpg) were 
separated on SDS-PAGE (7.5% polyacrylamide) and blotted with anti- 
P-tyrosine antibodies. Mol.wt. markers (x 10h3) are indicated by arrows 
at the left. The position of the 170x 10T3 mol.wt. tyrosine-phosporylated 
protein is indicated by the arrow at the right. 
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Fig. 2. Effect of EGF on tyrosine phosphorylation f total proteins and 
EGF-R in subconfluent Caco-2 cells. Lvsates from serum-starved cells 
not treated or treated with 200 ng EGF.ml-’ for 15 min at 37°C were 
used. (A) Imrnunopuritication f total proteins (2.5 mg) by anti-P- 
tyrosine antibody followed by blots with anti-P-tyrosine (a-p-Y) or 
anti-EGF-R (a-EGFR) antibodies. The A431 lane was loaded with a 
preparation ofmembrane phosphorylated protein from A43 1 cells stim- 
ulated by EGF. Mol.wt. markers (x lo-‘) are indicated at the left. The 
numbers at the right of the anti-P-tyrosine blot indicate the molwt. 
(~10~~) of the more represented putative EGF-R substrates. At 
the right of the anti-EGF-R blot the position of EGF-R is indicated. 
(B) Analysis of tyrosine phosphorylation f EGF-R in the absence and 
presence of EGF. Lysates containing 3.5 mg of protein were im- 
munoprecipitated by either control (Ctrl) or anti-EGF-R (a-EGFR) 
antibodies and proteins blotted with either anti-P-tyrosine (a-P-Y) or 
anti-EGF-R antibodies. Mol.wt. markers (x 10W3) are indicated at the 
left. The position of EGF-R is indicated by the arrows at the right. 
rose antibody. Proteins bound to anti-P-tyrosine-agarose were 
eluted and blotted with either anti-P-tyrosine or anti EGF-R 
antibodies. The left panel of Fig. 2A depicts the impressive 
stimulation by EGF treatment of phosphorylation of a 170.000 
mol.wt. protein migrating in the same position of the EGF-R 
from A 431 cells which was used as a reference protein (A 431 
lane). This co-migration suggested that the 170.000 mol.wt. 
protein observed in EGF-treated cells was the EGF-R. This 
was supported by the finding that using lysate of EGF-treated 
cells the 170.000 mol.wt. protein was recognized in blot by anti- 
EGF-R antibody (right panel of Fig. 2A). The left panel of 
Fig. 2A shows that in addition to the 170.000 mol.wt. protein 
those migrating at about 100.000 and 56-60.008 mol.wt. are also 
heavily tyrosine-phosphorylated in EGF-treated Caco-2 cells. 
Furthermore, above the EGF-R it is possible to detect stimula- 
tion of the 185.000 mol.wt. protein, the putative c-erb B2. 
3.3. Tyrosine phosphorylation of EGF-R 
To furnish additional and conclusive evidence that the 
170.000 mol.wt. tyrosine-phosphorylated protein observed in 
EGF-treated cells is indeed the EGF-R, Caco-2 cells treated or 
not with EGF were lysed. Each lysate was incubated with either 
control antibodies or anti-EGF-R antibodies. The immunopre- 
cipitated proteins were submitted to SDS-PAGE and blotted 
with either anti-P-tyrosine or anti-EGF-R antibodies. EGF 
treatment, did not modify the amount of EGF-R (right panel 
of Fig. 2B) whereas it significantly increased the interaction of 
EGF-R with anti-P-tyrosine antibodies (left panel of Fig. 2B). 
This experiment proved that EGF strongly increased tyrosine 
phosphorylation of EGF-R without affecting the level of this 
protein. 
3.4. Tyrosine phosphorylation of c-erb B2 
In the experiments to study total protein tyrosine phospho- 
rylation (Figs. 1 and 2A) EGF induced tyrosine phosphoryla- 
tion of a 185.000 mol.wt. protein we have tentatively identified 
with c-erb B2. To confirm this identification lysates from Caco- 
2 cells treated or not with EGF were incubated either with 
control antibodies or anti-c-erb B2 antibodies. The im- 
munoprecipitated proteins were submitted to SDS-PAGE and 
blotted with either anti-P-tyrosine or anti-c-erb B2 antibodies. 
As in the case of EGF-R, EGF treatment did not modify the 
amount of c-erb B2 whereas signiticantly stimulated tyrosine 
phosphorylation of this protein (Fig. 3). 
3.5. Analysis of ras-GAP-associated proteins 
Untreated or EGF-treated Caco-2 cells were lysed and ly- 
sates submitted to immunoprecipitation by either control or 
anti-ras-GAP antibodies. The immunoprecipitates were ana- 
lyzed by SDS-PAGE and finally blotted with anti-ras-GAP 
antibodies. The left panel of Fig. 4A shows that the 120.000 
mol.wt. ras-GAP was specifically immunoprecipitated by anti- 
Blot: M6 a-P-Y 
Fig. 3. Effect of EGF on tyrosine phosphorylation of c-erb B2 in 
subconfluent Caco-2 cells. Lysates containing 2.25 mg of protein were 
immunoprecipitated by either control (Ctrl) or an&-erb B2 (M6) 
anti-bodies and proteins blotted with either anti-P-tyrosine (a-P-Y) or 
anti-c-erb B2 antibodies (M6). Mol.wt. markers (x 10e3) are indicated 
at the left. The position of c-erb B2 is indicated at the right. 
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Fig. 4. Effect of EGF on protein association to ras-GAP in subconflu- 
ent Caco-2 cells. Lysates (4.5 mg) from serum-starved cells, untreated 
or treated for 5 min with 200 ng . ml-’ of EGF were used. (A) proteins 
were immunoprecipitated with anti-ras-GAP antibodies and blotted 
with either anti-ma-GAP (a-GAP) or anti-P-tyrosine (a-P-Y) or anti- 
~190 antibodies (a-p190). Immunoprecipitation with control antibodies 
(ctrl) was run in parallel and the precipitate was used for blot with 
anti-GAP antibodies. (B) proteins were submitted to immunoprecipita- 
tion with either control or anti-p190 antibodies. The precipitates were 
blotted with either anti-p190 (a-p190) or anti-P-tyrosine (a-P-Y) anti- 
bodies. Mol.wt. markers (x 10e3) are indicated at the left, the position 
of GAP, ~190 and putative p62 are indicated at the right. 
ras-GAP antibody and EGF treatment of cells did not affect 
the level of this protein. When a different aliquot of the same 
lysate sample immunoprecipitated by anti-ras-GAP antibodies 
was blotted with anti-P-tyrosine antibody, it became evident 
that EGF induced the appearance of two ras-GAP-associated 
tyrosine posphorylated proteins migrating at 62.000 and 
190.000 mol.wt. (middle panel of Fig. 4A). This result posed the 
question: did EGF induce tyrosine phosphorylation of two 
proteins already associated with ras-GAP before EGF treat- 
ment or did it induce association of two tyrosine 
phosphorylated proteins to ras-GAP, or did EGF induce both 
tyrosine phosphorylation and ras-GAP association of the two 
proteins? To answer these questions lysates from EGF-treated 
and untreated cells were immunoprecipitated with anti-ras- 
GAP antibodies, submitted to SDS-PAGE and blotted with 
anti-p190 antibodies. The right panel in Fig. 4A shows that 
only in cells treated with EGF was ~190 associated with ras- 
GAP. Furthermore cell lysates were immunoprecipitated with 
control or anti-p190 antibodies, proteins were electrophoreti- 
tally separated and finally blotted with either anti-p190 or 
anti-P-tyrosine antibodies. The right panel in Fig. 4B shows 
that ~190 was tyrosine-phosphorylated under basal conditions. 
Since the level of ~190 was slightly lower in the sample of 
EGF-treated cells (left panel in Fig. 4B) whereas tyrosine phos- 
phorylation was stronger in the same sample (right panel in Fig. 
4B), taken together the tindings indicated that EGF increased 
basal tyrosine phosphorylation of the ~190 protein. 
4. Jliscmion 
EGF is a factor that regulates growth, cell migration, cell-cell 
interaction, expression of digestive enzymes of intestinal cells 
[8,18]. This multiplicity of effects poses the question of how 
EGF can modulate these different processes. The present study 
demonstrates that EGF is able to strongly stimulate EGF-R 
phosphorylation of subconfluent proliferating Caco-2 cells. It 
has recently been reported that EGF stimulates the appearance 
of tyrosine phosphorylated EGF-R in suckling rat jejunum [19]. 
Stimulation of EGF-R tyrosine phosphorylation is a crucial 
process for the EGF action since it determines the affinity 
and/or the specificity of the receptor-intrinsic kinase for its 
cellular substrates [20] and tyrosine phosphorylation of the 
substrates is thought to represent he initial step of intracellular 
mitogenetic signal transduction. An EGF dose-response analy- 
sis has determined the concentrations at which EGF induces 
optimal tyrosine phosphorylation of different proteins in Caco- 
2 cells. Among the putative substrates of EGF-R we observed 
a tyrosine phosphorylated protein with mol.wt of 185.000 we 
identified with c-erb B2. This protein is related to the EGF-R 
[21] and its tyrosine phosphorylation is stimulated by EGF [22]. 
c-erb B2 is likely to be a physiological substrate of EGF-R. The 
interaction between EGF-R and c-erb B2 is unique in repre- 
senting a circuit in which one receptor appears to be directly 
phosphorylated by another in vivo and is the first example of 
a tyrosine kinase cascade in which both enzymes have been 
identified [22]. 
The EGF-dependence of p 190 association with ras-GAP we 
observe in Caco-2 cells has been previously studied with con- 
flicting results in other systems. In fact, while some authors 
observe equal amounts of ~190 and p62 proteins in ras-GAP 
complexes before and after cell EGF treatment [12], others have 
observed complexes of ras-GAP with p62 and ~190 proteins 
after EGF treatment alone [ 11,231. The ras-GAP-p190 complex 
reduces the GTP-ase activating activity of ras-GAP therefore 
increasing the active form of ras (ras-GTP) [12]. In addition, 
~190 contains different domains; one of them is located in the 
C-terminus [lo] and acts as a GAP specific for rho family 
proteins [13]. Therefore, the complex we observe between ras- 
GAP and ~190 may allow coupling of EGF stimulated signals 
to both ras and rho GTP-ases. 
EGF stimulates tyrosine phosphorylation of ~190 in subcon- 
fluent Caco-2 cells. This stimulation could be responsible for 
the association of p190 with the SH2 domains of ras-GAP [l 11. 
In EGF-treated cells we observe association of a tyrosine 
phosphorylated protein with mol.wt. of 62.000 mol.wt. to ras- 
GAP. This is most likely to be the p62 protein which has been 
found in complex with ras-GAP together with ~190 [11,12]. It 
has been suggested that this plays a role in DNA and RNA 
metabolism [ 171. 
Taken together our findings are consistent with the interpre- 
tation that in s&confluent Caco-2 cells EGF activation of the 
EGF-R tyrosine kinase and phosphorylation of critical sub- 
strates are required for the formation of ras-GAP-p190 com- 
20 A. Auricchio et al. IFEBS Letters 353 (1994) 16-20 
plex. This complex could have a crucial role for the EGF action 
on growth, cell-cell interaction motility and polarity of prolifer- 
ating intestinal cells. 
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